Stay updated on Pembrolizumab Post-ASCT in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page shows a revision from v3.4.2 to v3.4.3. This appears to be a minor update with no changes to study content.
    Difference
    0.1%
    Check dated 2026-03-06T18:42:56.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Site-level revision notes show Revision: v3.4.2 with dates 2026-01-26 and 2026-02-12, replacing v3.4.1; this does not affect the study data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-13T12:38:31.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. No visible changes to study content or navigation.
    Difference
    0.1%
    Check dated 2026-02-05T17:19:47.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.4 and has removed Revision: v3.3.3, a minor metadata update that does not alter study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T03:03:36.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Locations section added, listing California, Massachusetts, New York, and Texas under a single Locations heading; old state-specific location blocks replaced. HHS Vulnerability Disclosure link removed.
    Difference
    0.5%
    Check dated 2025-12-24T12:17:07.000Z thumbnail image
  8. Check
    112 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled in from PubMed and may not be about the study, and updated the revision to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T14:42:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Post-ASCT in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page.